Correspondence: When an article is eligible for submission of
Correspondence, a link to the response form is available within the full-text
article. You must be a
current subscriber who has activated the online portion of your subscription
in order to send a Correspondence. Any reader can read published
Correspondence.
Correspondence to:
BRIEF COMMUNICATIONS:
C. Goizet, B. Catargi, F. Tison, A. Tullio-Pelet, S. Hadj-Rabia, F. Pujol, A. Lagueny, S. Lyonnet, and D. Lacombe
Progressive bulbospinal amyotrophy in Triple A syndrome with AAAS gene mutation
Neurology 2002; 58: 962-965
[Abstract][Full text][PDF]
cyril.goizet{at}chu-bordeaux.fr Cyril Goizet, et al.
We thank Drs. de Carvalho and Houlden for their interest concerning
our adult patient with Allgrove (Triple A) syndrome and neurological
features.[5] We previously reported an adult patient with Triple A
syndrome and prominent bulbospinal amyotrophy associated with a mutation
identified in the AAAS gene.[1] Although we mentioned that motor neuron
involvement could occur in Triple A syndrome, [6] we must apologize to the
authors for not including their paper in our references.
The case reported by Bentes et al.[3] exhibited features of
bulbospinal amyotrophy on clinical examination and EMG, with in addition a
predominantly motor peripheral neuropathy.[3] The evolution of this case
was atypical with regard to the late recognition of alacrima and
compensated adrenal insufficiency. A homozygous missense mutation V313A
was recently identified in the AAAS gene.[4] Drs. de Carvalho and Houlden
describe additional cases with molecularly proven Triple A syndrome and
neurological presentation.[5] All manifested distal amyotrophy and
predominant motor neuropathy on nerve conduction studies, thus confirming
that peripheral neuropathy is a significant component of Triple A
syndrome.[6] The high frequency of amyotrophy led us to propose the eponym
of 5A syndrome.[1] Increased tone, brisk reflexes and Babinski signs were
reported in several cases, thereby arguing for an underestimation of CNS
involvement in Triple A syndrome. A systematic neurological assessment
should be proposed in every affected patient.
As achalasia, alacrima and adrenal insufficiency may result from an
autonomic neuropathy, a progressive degenerative process of the entire
nervous system has been proposed as the cause of the syndrome.[7] The
neurologic involvement may be the first feature to occur in Triple A
syndrome.
The AAAS gene is widely expressed in fetal and adult tissues, particularly
in endocrine and neuroendocrine derivatives and in brain.[2, 8] The
function of this gene coding for the ALADIN protein is still unknown.
ALADIN contains four WD (trp-asp) repeats and an amino acid triplet Ser-
His-Leu in the C-terminal end.[7] Although WD repeats are involved in
protein-protein interactions, the topogenic tripeptide has been shown to
direct proteins to and into peroxisomes.[9] Various target proteins in
different tissues may be involved, leading to different clinical
phenotypes. Further molecular and functional studies are needed to better
understand the disease.
References:
1. Goizet, C, Cartargi B, Tison F, et al. Progressive bulbospinal
amyotrophy in triple A syndrome with AAAS gene mutation. Neurology
2002;58:962-965.
2. Tulio-Pellet A, Salomon R, Hadj-Rabia S, et al. Mutation of a
novel WD-repeat protein gene in Allgrove (triple A) syndrome. Nat Gente
2000;26:332-335.
3. Bentes C, Santos-Bento M, de Sa J, Sales Luis ML, de Carvalho M.
Allgrove syndrome in adulthood. Muscle Nerve 2001;24:292-296.
4. Houlden H, Smith s, de Carvalho M, et al. Clinical and Genetic
characterization of families with Triple A (Allgrove) syndrome. Brain (in
press).
5. de Carvalho M, Houlden H Progressive bulbospinal amyotrophy in
Triple A syndrome with AAAS gene mutation. Neurology 2002; In press
6. Grant DB, Barnes ND, Dumic M, et al. Neurological and adrenal
dysfunction in the adrenal insufficiency/achalasia/alacrima (3A) syndrome.
Arch Dis Child 1993;68:779-782.
7. Gazarian M, Cowell CT, Bonney M, Grigor WG. The “4A” syndrome:
adrenocortical insufficiency associated with achalasia, alacrima,
autonomic and other neurological abnormalities. Eur J Pediatr 1995;154:18-
23.
8. Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A.
Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein
gene. Hum Mol Genet 2001;10:283-290.
9. Gould SJ, Valle D. Peroxisome biogenesis disorders: genetic and
cell biology. Trends Genet 2000;16:340-345.
Progressive bulbospinal amyotrophy in Triple A syndrome with AAAS gene mutation
17 July 2002
Mamede deCarvalho Hospital de Santa Maria Lisboa Portugal, Henry Houlden
mamedemg{at}mail.telepac.pt Mamede deCarvalho, et al.
Goizet et al. [1] claimed to report the first adult case of Allgrove
syndrome (AS) presenting with prominent bulbospinal amyotrophy. This
patient had hypoglycemia, hyperpigmentation, mental retardation, and
alacrima since childhood. On neurologic examination she showed symmetric
four-limb amyotrophy, predominantly distal, upper motor neuron signs,
bulbar dysarthria and swallowing difficulties. Sequencing of the patient’s
DNA identified a homozygous nonsense mutation at condon 478 in exon 16 of
the AAAS gene 1, which have been implied as responsible for this syndrome.
[2]
We have previously reported a similar case. [3] Our patient, a man
with a past history of achalasia, developed progressive spastic
tetraparesis, distal limb atrophy, dysarthria, and dysphagia at 35 years.
He had no familial history, and his parents had no consanguinity. A
clinical diagnosis of ALS was considered before neurophysiological
investigation, which disclosed a polyneuropathy and a prolonged central
conduction time on transcranial magnetic stimulation. One year later, he
developed dysautonomic symptoms. Laboratory studies confirmed latent
adrenal insufficiency. This patient has two previously unidentified
homozygous mutations, one that caused the amino acid change valine to
alanine at codon 313 and another that causes a deletion of ATAA in the
poly a tract (base pairs 1730-1733). [4] The exonic mutation is likely
the pathogenic mutation in this family as the deletion is after the stop
codon of the triple a gene although mutations that disrupt the poly A
tract can be pathogenic by affecting mRNA stability or splicing. [5]
We studied in addition five other families with AS. [4] They had
mutations spread throughout the triple A gene in exons 1, 2, 7, 8, 10, 11,
12, 13 and 16. [4] We identified a number of associated cranial nerve
abnormalities in these pedigrees including two families who had bilateral
hypoglossal nerve palsies and dysarthria. In all there was pes cavus and
predominantly distal weakness and wasting in the upper and lower limbs in
all families. In the upper limbs this was patchy with marked weakness in
an ulnar distribution and wasting of the hypothenar eminence. The tone
was generally increased in the upper and lower limbs, reflexes were brisk
in the upper limbs but the ankle jerks were lost, plantar reflexes were
extensor in one family and equivocal in another. Nerve conduction studies
showed predominant motor neuropathy, with selective involvement of ulnar
nerves in the upper limbs, but no entrapment of this nerve at elbow. [4]
Our patient had neurologic symptoms before overt autonomic
involvement, [3] which makes this case more atypical than the one reported
by Goizet et al. [1] We agree with the authors that the possibility of
Allgrove syndrome must be borne in our mind even when adult patients
presenting with slowly progressive bulbospinal amyotrophy are evaluated.
References:
1) Goizet C, Cartargi B, Tison F, et al. Progressive bulbospinal
amyotrophy in triple A syndrome with AAAS gene mutation. Neurology
2002;58:962-965.
2) Tulio-Pellet A, Salomon R, Hadj-Rabia S et al. Mutation of a
novel WD-repeat protein gene in Allgrove (triple A) syndrome. Nat Gente
2000;26:332-335.
3) Bentes C, Santos-Bento M, de Sa J, Sales Luis ML, de Carvalho
M. Allgrove syndrome in adulthood. Muscle Nerve 2001;24:292-296.
4) Houlden H, Smith S, de Carvalho M, et al. Clinical and Genetic
characterization of families with Triple A (Allgrove) syndrome. Brain (in
press).
5) Beaudoing E, Freier S, Wyatt JR, Claverie J-M, Gautheret D.
Patterns of Variant Polyadenylation Signal Usage in Human Genes. Genome
Res 2000;10:1001-1010.